Literature DB >> 9147405

Abnormal distribution of neurofilament L in neurons with Alzheimer's disease.

Y Nakamura1, R Hasimoto, Y Kashiwagi, Y Miyamae, K Shinosaki, T Nishikawa, H Hattori, T Kudo, M Takeda.   

Abstract

Abnormality of cytoskeletal proteins is closely related to the pathology of Alzheimer's disease. As neurofilament proteins are major cytoskeletal components of neurons, abnormality of neurofilaments is proposed in brain with Alzheimer's disease. Free-floating sections of the hippocampus with Alzheimer's disease were studied immunohistochemically, using a polyclonal antibody specifically bound to the tail region of neurofilament L (NF-L). In brains with early onset type of Alzheimer's disease, many neurons and dystrophic neurites were labeled by the antibody, while these observations were not seen in either brains with late onset type or control brains. Double immunohistochemical staining of NF-L and tau protein demonstrated that abnormal deposition of NF-L was not always accompanied with that of tau protein, indicating that the abnormal deposition of NF-L might not occur in parallel with that of tau protein. These observations suggest the involvement of neurofilament proteins on the pathology of Alzheimer's disease in a different way than tau protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9147405     DOI: 10.1016/s0304-3940(97)00223-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Does beta-amyloid plaque formation cause structural injury to neuronal processes?

Authors:  Adele Woodhouse; Adrian K West; Jyoti A Chuckowree; James C Vickers; Tracey C Dickson
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

2.  Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.

Authors:  Katherine Garcia Ravelli; Barbara Dos Anjos Rosário; Rosana Camarini; Marina Sorrentino Hernandes; Luiz Roberto Britto
Journal:  Neurotox Res       Date:  2016-12-02       Impact factor: 3.911

3.  Specific human astrocyte subtype revealed by affinity purified GFAP antibody; unpurified serum cross-reacts with neurofilament-L in Alzheimer.

Authors:  Jinte Middeldorp; Simone A van den Berge; Eleonora Aronica; Dave Speijer; Elly M Hol
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.